HSTM vs. OMCL, MDRX, CRTX, IAC, DOCN, MGNI, DV, WB, TRIP, and VNET
Should you be buying HealthStream stock or one of its competitors? The main competitors of HealthStream include Omnicell (OMCL), Veradigm (MDRX), Cortexyme (CRTX), IAC (IAC), DigitalOcean (DOCN), Magnite (MGNI), DoubleVerify (DV), Weibo (WB), Tripadvisor (TRIP), and VNET Group (VNET).
HealthStream vs. Its Competitors
HealthStream (NASDAQ:HSTM) and Omnicell (NASDAQ:OMCL) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.
HealthStream has higher earnings, but lower revenue than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.
HealthStream has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500.
In the previous week, HealthStream had 1 more articles in the media than Omnicell. MarketBeat recorded 6 mentions for HealthStream and 5 mentions for Omnicell. HealthStream's average media sentiment score of 1.28 beat Omnicell's score of 0.81 indicating that HealthStream is being referred to more favorably in the media.
HealthStream presently has a consensus target price of $31.50, indicating a potential upside of 12.98%. Omnicell has a consensus target price of $44.83, indicating a potential upside of 47.53%. Given Omnicell's higher probable upside, analysts clearly believe Omnicell is more favorable than HealthStream.
HealthStream has a net margin of 6.84% compared to Omnicell's net margin of 1.13%. HealthStream's return on equity of 5.67% beat Omnicell's return on equity.
Omnicell received 45 more outperform votes than HealthStream when rated by MarketBeat users. Likewise, 66.75% of users gave Omnicell an outperform vote while only 66.43% of users gave HealthStream an outperform vote.
69.6% of HealthStream shares are held by institutional investors. Comparatively, 97.7% of Omnicell shares are held by institutional investors. 20.5% of HealthStream shares are held by company insiders. Comparatively, 2.5% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
HealthStream beats Omnicell on 11 of the 19 factors compared between the two stocks.
Get HealthStream News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSTM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HSTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HealthStream Competitors List
Related Companies and Tools
This page (NASDAQ:HSTM) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy HSTM Stock Free HSTM Stock Alerts